FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Eugia US Nicardipine Hydrochloride Injection Recall

Nicardipine Hydrochloride Injection (2

Eugia US LLC · East Windsor, NJ

Risk level
Class II
Reported by FDA
Mar 27, 2024
Recall ID
D-0390-2024
Check your lot numberHow we source this data

Summary

Eugia US recalled Nicardipine Hydrochloride Injection starting Feb 20, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0390-2024 on Mar 27, 2024. Reason: Failed Impurities/Degradation Specifications: Out of specification for organic impurities. Status: Ongoing.

Why it was recalled

Failed Impurities/Degradation Specifications: Out of specification for organic impurities

Product description

Nicardipine Hydrochloride Injection (2.5mg/mL), US, 25mg per 10mL, 10mL Vial, Rx only, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520 NDC 55150-183-10

Lot numbers, UPCs & expiration codes

Lot #: 3NC23002, Exp. Date 7/24; 3NC22013, 3NC22014, 3NC22015, 3NC22016, 3NC22017, 3NC22018, Exp. Date 2/24; 3NC22020, Exp. Date 3/24

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0390-2024
Classification
Class II
Status
Ongoing
Recall initiated
Feb 20, 2024
FDA report date
Mar 27, 2024
Quantity
335,940 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Eugia US LLC

Original FDA data

Every field from FDA enforcement report D-0390-2024, exactly as published.

Show all FDA fields
City
East Windsor
State
NJ
Status
Ongoing
Country
United States
Event ID
94073
Address
279 Princeton Hightstown Rd
Code information
Lot #: 3NC23002, Exp. Date 7/24; 3NC22013, 3NC22014, 3NC22015, 3NC22016, 3NC22017, 3NC22018, Exp. Date 2/24; 3NC22020, Exp. Date 3/24
Postal code
08520-1401
Report date
Mar 27, 2024
Product type
Drugs
Recall number
D-0390-2024
Classification
Class II
Recalling firm
Eugia US LLC
Product quantity
335,940 vials
Reason for recall
Failed Impurities/Degradation Specifications: Out of specification for organic impurities
Voluntary / mandated
Voluntary: Firm initiated
Product description
Nicardipine Hydrochloride Injection (2.5mg/mL), US, 25mg per 10mL, 10mL Vial, Rx only, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520 NDC 55150-183-10
Distribution pattern
Nationwide within the United States
Recall initiation date
Feb 20, 2024
Initial firm notification
Letter
Center classification date
Mar 19, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0390-2024, published Mar 27, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls